News

INDIGO Biosciences Expands Alternative Species Portfolio With Six New Receptor Assays For Cross-Species Drug Screening
STATE COLLEGE, PA, UNITED STATES, July 29, 2025 /EINPresswire / -- INDIGO Biosciences, a global leader in cell-based assay solutions, announced today the expansion of its alternative species line with ...
European Medical Journal11h
Diffusion MRI Predicts Breast Cancer Response Early in Chemotherapy
ACCURATELY predicting which breast cancer patients will respond completely to neoadjuvant chemotherapy (NAC) remains a ...
Triple-Negative Breast Cancer Market Gearing Up For Impressive Growth At A CAGR Of 4.7% During The Forecast Period (2025-2034) Delveinsight
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted th ...
DelveInsight Business Research, LLP: Triple-Negative Breast Cancer Market Gearing Up for Impressive Growth at a CAGR of 4.7% During the Forecast Period (2025-2034) | DelveInsight
The triple-negative breast cancer market is expected to grow due to rising incidence rates, increasing awareness, advancements in targeted therapies, ongoing clinical trials, improved diagnostics ...
Euro Weekly News6h
New treatment halts triple-negative breast cancer
Spanish researchers have achieved a significant breakthrough in the fight against the deadliest form of breast ...